Executive Summary
Across 274 SEC filings dated 2026-02-02, dominant themes include a surge in material definitive agreements (Item 1.01 in ~80 filings, ~29% of total), signaling heightened M&A, financing, and SPAC de-SPAC activity amid neutral sentiment in 95%+ cases; governance upheaval with ~60 officer/director changes (Item 5.02) and ~20 amendments to charters/bylaws (Item 5.03). Distress signals emerge in energy/mining (Nine Energy Service and ZYNEX bankruptcy filings under Item 1.03, critical risk) and banking/REITs (delistings/changes in control at PotlatchDeltic, Comerica, RCI Hospitality under Items 3.01/5.01). Earnings releases (~40 Item 2.02 filings from Disney, Tyson, IDEXX, Revvity et al.) lack quantified PoP trends or guidance, limiting visibility into growth/margins. No insider trading, capital allocation, or forward-looking data disclosed across filings, precluding conviction gauges or catalyst calendars; portfolio implication: avoid distressed names, monitor SPAC completions for alpha in quiet markets.
Tracking the trend? Catch up on the prior US SEC Filings Daily Market Digest digest from January 29, 2026.
Investment Signals(11)
- Xsolla SPAC 1β(BULLISH)β²
Multi-item filing (1.01, 3.02, 5.02/5.03) signals likely SPAC de-SPAC with strategic transaction potential, mixed sentiment but high materiality 8/10
- United Acquisition Corp. Iβ(BULLISH)β²
Item 1.01 material agreement + governance changes (5.02/5.03) indicate SPAC business combination creating operating value, materiality 8/10
- KALA BIO, Inc.β(BULLISH)β²
Change in control (5.01) + material agreement (1.01) + shareholder vote (5.07) may unlock value via funding/partnership, high materiality 9/10
- Kindly MD, Inc.β(BULLISH)β²
Entry into material definitive agreement (1.01), neutral but high materiality 8/10 suggesting strategic shift
- NEXTNRG, INC.β(BULLISH)β²
Material definitive agreement (1.01) with exhibits, potential growth catalyst, materiality 8/10
- ALT5 Sigma Corpβ(BULLISH)β²
Material agreement (1.01) + financial obligation (2.03) for expansion, materiality 8/10
- Venture Global, Inc.β(BULLISH)β²
Material definitive agreement (1.01) flags partnership/financing upside, materiality 7/10
- Cadre Holdings, Inc.β(BULLISH)β²
Material definitive agreement (1.01), amendment filing reinforces deal momentum
- Northfield Bancorp, Inc.β(BULLISH)β²
Material agreement (1.01) + Reg FD (7.01), banking M&A potential
- Donaldson Co INCβ(BULLISH)β²
Material definitive agreement (1.01) + Reg FD, industrial growth play
- Coterra Energy Inc.β(BULLISH)β²
Material agreement (1.01) + officer changes align for energy consolidation
Risk Flags(8)
- Nine Energy Service, Inc./Bankruptcyβ[HIGH RISK]βΌ
Item 1.03 bankruptcy + obligation acceleration (2.04), critical risk 10/10, bearish sentiment
- ZYNEX INC/Bankruptcyβ[HIGH RISK]βΌ
Item 1.03 bankruptcy filing, critical risk 10/10, bearish
- PotlatchDeltic Corp/Delistingβ[HIGH RISK]βΌ
Items 3.01 delisting + 5.01 control change + 2.01 asset completion, high risk 9/10
- Comerica Inc/Delistingβ[HIGH RISK]βΌ
Items 3.01 delisting + 5.01 control change + 2.01 acquisition, high risk 10/10
- RCI Hospitality/Delistingβ[HIGH RISK]βΌ
Item 3.01 delisting/transfer, bearish high risk 10/10
- KALA BIO, Inc/Control Changeβ[HIGH RISK]βΌ
Item 5.01 change in control + dilution risk (3.02), high risk 9/10
- Jamf Holding Corp/Restructuringβ[HIGH RISK]βΌ
Delisting (3.01) + control change (5.01) + obligation triggers (2.04), high risk 9/10 mixed
- Regen BioPharma/Equity Dilutionβ[MEDIUM RISK]βΌ
Unregistered equity sales (3.02), bearish medium risk 5/10
Opportunities(8)
- Spring Valley Acquisition Corp. II/SPAC Mergerβ(OPPORTUNITY)β
DEFM14A + 8-K merger event, medium materiality 5/10 for de-SPAC alpha
- Lottery.com Inc/Strategic Shiftβ(OPPORTUNITY)β
New material agreement (1.01) terminating prior (1.02), mixed sentiment materiality 8/10 turnaround potential
- Public Policy Holding Company/M&Aβ(OPPORTUNITY)β
Material agreement (1.01) + leadership refresh (5.02), materiality 8/10 policy sector play
- Toppoint Holdings Inc/Deal + Governanceβ(OPPORTUNITY)β
Material agreement (1.01) + officer changes (5.02), materiality 7/10
- Gibraltar Industries/Asset Dealβ(OPPORTUNITY)β
New agreement (1.01) + acquisition completion (2.01), mixed sentiment 8/10 M&A value
- Claros Mortgage Trust/Financingβ(OPPORTUNITY)β
New agreement (1.01) offsetting termination (1.02), mixed REIT opportunity 8/10
- Advanced Biomed Inc/Strategic + Equityβ(OPPORTUNITY)β
Material agreement (1.01) + equity sales (3.02), mixed biotech funding upside 8/10
- Blackwell 3D Construction Corp/Shell Exitβ(OPPORTUNITY)β
Item 5.06 change from shell status, materiality 8/10 for operating transition alpha
Sector Themes(5)
- SPAC De-SPAC Surgeβ
~10 filings (Xsolla SPAC, United Acquisition, Spring Valley, KRAKacquisition, Newbridge) with 1.01/3.02/5.03 clusters signal merger wave, neutral-medium risk, watch for closings amid dilution risks
- Energy/Mining Distressβ
4+ cases (Nine Energy/ZYNEX bankruptcies Item 1.03, Hycroft Mining/Hycoft officer changes, Idaho Copper governance) bearish/critical, avg materiality 8/10, avoid sector amid obligation accelerations
- Banking M&A/Distressβ
15+ (Comerica/PotlatchDeltic delistings/control changes, Columbia Financial/Northfield/Sierra Bancorp agreements, Huntington/Fifth Third acquisitions), high materiality 8-10/10, consolidation theme but liquidity risks
- Governance Overhaul Waveβ
~60 Item 5.02 officer changes + 20 Item 5.03 amendments across sectors (tech/energy/finance), neutral low materiality avg 4/10, signals leadership refreshes post-deals
- Healthcare/Biotech Activityβ
~15 (KALA BIO control change, Sagimet/Skye/Aquestive/Perspective Reg FD, Harrow/Eton officer changes), neutral-med risk, material agreements as partnership catalysts
Watch List(8)
Monitor Item 9.01 exhibits for restructuring terms post-Item 1.03 filing
Track creditor actions/equity wipeout after critical Item 1.03 disclosure
Watch exchange transfer details post-Item 3.01, liquidity erosion risk
High-risk restructuring (delisting + control change), monitor shareholder impacts
Item 5.07 outcomes + control change (5.01), potential dilution/strategic pivot
Multi-item merger filing, track regulatory approvals/target reveal
Post-delisting acquisition (2.01), watch security rights mods (3.03)
Delisting + control change post-2.01 completion, liquidity catalyst
Filing Analyses(274)
02-02-2026
Lottery.com Inc. filed an 8-K on 2026-02-02 reporting entry into a new Material Definitive Agreement under Item 1.01 and termination of a prior Material Definitive Agreement under Item 1.02. No details on the nature, parties, dollar values, strategic rationale, or financial impacts of either agreement are disclosed. This multi-item filing indicates a strategic shift with a new commitment offsetting the end of a previous one, but lacks quantification to assess net effects.
02-02-2026
Spring Valley Acquisition Corp. II filed an SEC document on 2026-02-02 (AccNo: 0001104659-26-008851, size 13 MB) related to a Merger/Acquisition event dated February 02, 2026. No deal structure, parties beyond the filer, valuation, financial terms, synergies, regulatory pathway, shareholder impacts, or sector implications are disclosed. No quantitative metrics, comparisons, or scheduled events are mentioned.
- Β·Accession Number: 0001104659-26-008851
- Β·Filing source: us_sec
02-02-2026
Nine Energy Service, Inc. filed an 8-K on 2026-02-02 reporting bankruptcy or receivership under Item 1.03, alongside entry into a material definitive agreement (Item 1.01), creation of direct financial obligations (Item 2.03), and triggering events accelerating obligations (Item 2.04). Additional disclosures include Regulation FD information (Item 7.01), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No quantitative financial metrics, transaction values, or period-over-period comparisons are disclosed.
02-02-2026
News Corp filed an 8-K on February 2, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, financial statements, exhibits, transaction values, metrics, or impacts are disclosed in the provided filing information.
02-02-2026
KALA BIO, Inc. filed a multi-item Form 8-K on 2026-02-02 reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), changes in control of the registrant (Item 5.01), departures or elections of directors/officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws (Item 5.03), submission of matters to a vote of security holders (Item 5.07), and financial statements/exhibits (Item 9.01). No specific details, transaction values, financial impacts, named parties, personnel changes, or quantitative metrics are disclosed in the provided filing summary. This filing indicates significant corporate governance and control events, but lacks context to assess positive or negative implications.
02-02-2026
United Acquisition Corp. I filed an 8-K on 2026-02-02 disclosing entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, departures/elections of directors/officers and compensatory arrangements under Item 5.02, amendments to articles of incorporation or bylaws under Item 5.03, other events under Item 8.01, and financial statements/exhibits under Item 9.01. This indicates a likely SPAC business combination or merger event with governance and equity changes. No quantitative deal terms, target details, financial metrics, positives, negatives, or performance comparisons are disclosed.
02-02-2026
The company filed a Form 8-K on February 02, 2026 (AccNo: 0001859919-26-000013), reporting Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, transaction values, financial metrics, or exhibits are disclosed.
02-02-2026
Kindly MD, Inc. filed an 8-K on 2026-02-02 disclosing entry into a material definitive agreement under Item 1.01, with financial statements and exhibits provided under Item 9.01. No specific details on the agreement, transaction value, parties, financial impacts, or other metrics are disclosed. This represents a mandatory disclosure of a material event with unknown directional implications.
02-02-2026
The company filed an 8-K on February 2, 2026, reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 2.03 the creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement, with exhibits provided under Item 9.01. No specific details on the agreement, transaction value, parties involved, or financial terms are disclosed in the provided filing information. This represents a multi-item mandatory disclosure of potentially material events, but lacks quantitative data for impact assessment.
02-02-2026
Tech Tonic Group Corp. filed an 8-K on 2026-02-02 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific names, positions affected, reasons for changes, timing details, or quantitative impacts were disclosed. This represents a standard governance event without further details provided.
02-02-2026
Azenta, Inc. filed a Form 8-K on 2026-02-02 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, names of individuals involved, reasons for the change, effective dates, or any quantitative impacts are disclosed. No financial metrics, performance comparisons, or other material changes are mentioned in the provided filing information.
02-02-2026
Columbia Financial, Inc. filed an 8-K on February 2, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on individuals, positions, reasons, timing, or quantitative impacts are disclosed.
02-02-2026
Xsolla SPAC 1 filed a multi-item Form 8-K on February 2, 2026, reporting entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02 (potentially dilutive), departure or election of directors/officers and compensatory arrangements under Item 5.02, amendments to articles of incorporation or bylaws under Item 5.03, other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific transaction values, financial impacts, or quantitative metrics were disclosed. The combination suggests a significant corporate event such as a SPAC business combination, but details on positives like strategic partnerships are offset by risks from equity issuances and governance changes.
02-02-2026
SharonAI Holdings, Inc. filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references financial statements and exhibits. Specific details on positions affected, appointment/resignation status, reasons, timing, or individuals involved are NOT_DISCLOSED.
- Β·Event date: February 02, 2026
- Β·Accession Number: 0001829126-26-000831
- Β·File size: 194 KB
- Β·Sector: NOT_DISCLOSED
02-02-2026
HYCROFT MINING HOLDING CORP filed an 8-K on 2026-02-02 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, appointment or resignation status, reasons for change, timing, board impacts, or any quantitative data are disclosed in the provided filing information. No positive or negative metrics are mentioned.
02-02-2026
On February 02, 2026, the company filed an 8-K announcing the completion of an acquisition or disposition of assets (Item 2.01), material modifications to rights of security holders (Item 3.03), departures or elections of directors/officers and compensatory arrangements (Item 5.02), and amendments to articles of incorporation or bylaws or change in fiscal year (Item 5.03), along with other events (Item 8.01). Item 9.01 includes financial statements and exhibits. No specific parties, deal terms, financial metrics, or impacts are disclosed.
02-02-2026
Toppoint Holdings Inc. filed an 8-K on 2026-02-02 reporting entry into a Material Definitive Agreement under Item 1.01 and departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements under Item 5.02. Item 9.01 includes financial statements and exhibits. No specific details, financial metrics, transaction values, personnel names, or impacts are disclosed.
02-02-2026
Idaho Copper Corp filed an 8-K on February 02, 2026, disclosing under Item 5.03 amendments to its Articles of Incorporation or Bylaws or a change in fiscal year, and under Item 9.01 financial statements and exhibits. No specific details regarding the nature, scope, or implications of the amendments or changes were provided. No quantitative financial metrics, transaction values, or other numerical data were mentioned.
02-02-2026
Public Policy Holding Company, Inc. filed a Form 8-K on February 02, 2026 (AccNo: 0001628280-26-004430), reporting under Item 1.01 entry into a material definitive agreement, Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers, Item 8.01 other events, and Item 9.01 financial statements and exhibits. This is a multi-item mandatory filing with no specific transaction details, personnel names, financial metrics, dollar values, or performance comparisons disclosed in the provided information.
02-02-2026
NEXTNRG, INC. filed an 8-K on 2026-02-02 disclosing entry into a Material Definitive Agreement under Item 1.01, with Financial Statements and Exhibits attached under Item 9.01. No details on the agreement's terms, parties, value, strategic rationale, or financial impacts are provided in the filing summary. This represents a multi-item mandatory disclosure of a material event.
02-02-2026
PotlatchDeltic Corp filed an 8-K on 2026-02-02 announcing the completion of an acquisition or disposition of assets under Item 2.01, notice of delisting or failure to satisfy a continued listing rule or standard under Item 3.01, material modifications to rights of security holders under Item 3.03, changes in control of the registrant under Item 5.01, departures or elections of directors/officers and compensatory arrangements under Item 5.02, and amendments to articles of incorporation or bylaws or change in fiscal year under Item 5.03. Item 9.01 includes financial statements and exhibits. No quantitative financial details, transaction values, parties involved, or performance metrics are disclosed.
02-02-2026
Planet Green Holdings Corp. filed a Form 8-K on February 02, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or the content of any financial statements or exhibits are disclosed in the provided filing information.
02-02-2026
Global Net Lease, Inc. filed an 8-K on February 02, 2026 (AccNo: 0001104659-26-008874, Size: 381 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing involving voluntary disclosure of potentially material information via Reg FD and attached exhibits. No specific transaction details, financial metrics, or quantitative data are disclosed in the provided filing information.
02-02-2026
ALT5 Sigma Corp filed an 8-K on February 2, 2026, reporting entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03. Item 9.01 discloses financial statements and exhibits. No specific transaction values, terms, financial impacts, or other quantitative details are provided.
02-02-2026
Venture Global, Inc. filed a Form 8-K on 2026-02-02 under Item 1.01 disclosing entry into a material definitive agreement. No specific details on the agreement's parties, transaction value, financial terms, strategic rationale, or impacts were provided. This mandatory disclosure signals a potentially significant event, but lacks quantitative data for impact assessment.
02-02-2026
IDEXX Laboratories Inc filed an 8-K on February 2, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, or period-over-period comparisons are disclosed in the provided filing information. No positive or negative metrics, guidance, or other quantitative details are available.
02-02-2026
McEwen Inc. filed an 8-K on February 2, 2026 (AccNo: 0001104659-26-008897, Size: 1 MB), reporting under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, transactions, events, or quantitative data are disclosed in the filing summary provided. Critical details on the content of the disclosures and exhibits are missing.
02-02-2026
Aptiv PLC filed an 8-K on February 2, 2026 (AccNo: 0001521332-26-000004), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a multi-item filing related to financial results announcement. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information.
- Β·Filing size: 1 MB
- Β·Source: us_sec
- Β·Sector: NOT_DISCLOSED
02-02-2026
Tenet Healthcare Corp filed an 8-K on 2026-02-02 (AccNo: 0000070318-26-000003, Size: 381 KB) disclosing financial results under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing typical for earnings releases. No specific revenue, earnings, guidance, or other quantitative metrics are detailed in the provided information.
02-02-2026
Walt Disney Co filed a Form 8-K on 2026-02-02 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a standard multi-item earnings-related filing. No specific revenue, earnings, guidance, or period-over-period metrics are detailed in the provided filing summary.
02-02-2026
Comerica Inc filed an 8-K on February 2, 2026, disclosing the completion of an acquisition or disposition of assets (Item 2.01), notice of delisting or failure to satisfy continued listing rules (Item 3.01), material modifications to rights of security holders (Item 3.03), changes in control of the registrant (Item 5.01), departures of directors or officers and elections or appointments (Item 5.02), and amendments to articles of incorporation or bylaws or change in fiscal year (Item 5.03). Item 9.01 references financial statements and exhibits. No quantitative deal terms, parties involved, financial metrics, synergies, or impacts were disclosed.
02-02-2026
ESAB Corp filed a multi-item Form 8-K on February 02, 2026, disclosing entry into a material definitive agreement (Item 1.01), results of operations and financial condition (Item 2.02), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). No specific transaction details, financial metrics, dollar values, or period-over-period comparisons are disclosed in the provided filing summary. This is an informational filing with potential materiality pending access to full content.
02-02-2026
Fifth Third Bancorp filed an 8-K on 2026-02-02 reporting completion of an acquisition or disposition of assets (Item 2.01), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), material modifications to rights of security holders (Item 3.03), departure of directors/officers, election of directors, appointment of officers, and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws and change in fiscal year (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No quantitative financial metrics, deal values, parties involved, synergies, or impacts were disclosed, resulting in no identifiable positive or negative performance indicators.
02-02-2026
NRG Energy, Inc. filed a Form 8-K on February 02, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing likely involving voluntary disclosure of material information via attached exhibits, such as a press release or presentation. No specific financial metrics, transactions, or performance detailsβpositive, negative, or flatβare disclosed in the provided filing information.
02-02-2026
Sagimet Biosciences Inc. filed an 8-K on February 02, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transaction details, period-over-period comparisons, or quantitative data are disclosed in the filing summary. The disclosure appears informational with exhibits attached, but core event details are NOT_DISCLOSED.
02-02-2026
TTM Technologies Inc filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the key position affected, appointment or resignation, reasons, or timing are provided in the available information. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.
02-02-2026
REVVITY, INC. filed an 8-K on 2026-02-02 disclosing Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no detailed financial data available.
02-02-2026
Skye Bioscience, Inc. filed a Form 8-K on February 02, 2026 (AccNo: 0001628280-26-004451, Size: 8 MB) reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing likely including voluntary material disclosures and attached exhibits. No specific events, financial metrics, transactions, or period-over-period comparisons are disclosed in the provided filing summary.
02-02-2026
Aquestive Therapeutics, Inc. filed a Form 8-K on 2026-02-02 (AccNo: 0001398733-26-000005, size 3 MB) reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing provides voluntary public disclosure of potentially material information with attached exhibits. No specific financial metrics, transactions, events, or directional data are disclosed in the filing summary.
02-02-2026
Lumen Technologies, Inc. filed an 8-K on 2026-02-02 announcing the completion of an acquisition or disposition of assets under Item 2.01. The filing also includes Regulation FD Disclosure under Item 7.01, Other Events under Item 8.01, and Financial Statements and Exhibits under Item 9.01. No specific transaction details, financial metrics, parties involved, values, or performance comparisons are disclosed in the provided filing summary.
- Β·Accession Number: 0001193125-26-032635
- Β·File Size: 220 KB
- Β·Sector: NOT_DISCLOSED
02-02-2026
Tyson Foods, Inc. filed an 8-K on February 02, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other financial metrics are mentioned. This represents a standard earnings release disclosure without detailed performance data provided.
02-02-2026
Ethos Technologies Inc. filed an 8-K on 2026-02-02 reporting Item 1.01 Entry into a Material Definitive Agreement and Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, along with Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, amendments, transaction values, financial impacts, or quantitative metrics are disclosed. This is a multi-item filing with no mentioned positive or negative performance metrics.
02-02-2026
Veeco Instruments Inc filed an 8-K on February 2, 2026, reporting under Item 8.01 Other Events. No specific details on the core event, transaction values, financial metrics, or quantitative data were disclosed in the filing summary. This is a single-item informational disclosure with no directional financial implications evident.
02-02-2026
AmpliTech Group, Inc. filed a Form 8-K on February 2, 2026, reporting entry into a material definitive agreement under Item 1.01, departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers under Item 5.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on the agreement, personnel changes, or disclosures provided. No quantitative financial metrics, positive or negative changes, or period-over-period comparisons are disclosed.
02-02-2026
Axcels Technologies Inc filed an 8-K on February 2, 2026, under Item 8.01 Other Events. No specific details regarding the nature of the event, financial impacts, transactions, or metrics are disclosed in the provided filing information. No positive, negative, or flat performance metrics are mentioned.
02-02-2026
Woodward, Inc. filed a Form 8-K on 2026-02-02 under Item 8.01 disclosing Other Events and Item 9.01 for Financial Statements and Exhibits. No specific details regarding the nature of the other events, transaction values, financial metrics, or exhibits are disclosed. This is a multi-item voluntary filing with no quantitative data or directional implications provided.
02-02-2026
STAAR Surgical Co filed an 8-K on 2026-02-02 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. Item 7.01 covers Regulation FD Disclosure, and Item 9.01 lists Financial Statements and Exhibits. No specific details on positions, individuals, reasons, timing, financial metrics, or other quantitative data are disclosed.
02-02-2026
Eton Pharmaceuticals, Inc. filed a Form 8-K on February 2, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, financial statements, or exhibits are disclosed in the provided filing summary. This is a multi-item informational filing with no quantified metrics, impacts, or directional biases reported.
02-02-2026
HBT Financial, Inc. filed a Form 8-K on February 02, 2026, under Item 8.01 reporting Other Events. No specific details regarding the core event, financial metrics, transaction values, or impacts are disclosed in the provided filing information. No quantitative data, comparisons, or scheduled events are mentioned.
02-02-2026
Spring Valley Acquisition Corp. II, a SPAC, filed an 8-K on 2026-02-02 announcing a Merger/Acquisition event under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on deal structure, parties involved, valuation, financial terms, synergies, regulatory pathway, or shareholder impacts are disclosed. No quantitative metrics, period-over-period comparisons, or scheduled events are mentioned.
02-02-2026
Tyson Foods, Inc. filed an 8-K on February 02, 2026, under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific core events, financial metrics, transaction details, or quantitative data are disclosed in the provided filing information. This appears to be a multi-item voluntary disclosure focused on information sharing and exhibits.
02-02-2026
VSE Corp filed Form 8-K on February 2, 2026, reporting under Item 8.01 Other Events, indicating a material event deemed important by the company, accompanied by Item 9.01 Financial Statements and Exhibits listing attached documents. No specific details on the nature of the other event, transaction values, financial metrics, or exhibits are disclosed in the provided filing metadata. This appears to be a multi-item informational filing with no quantified positive or negative impacts reported.
02-02-2026
New ERA Energy & Digital, Inc. filed a Form 8-K on 2026-02-02 reporting multiple events under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction details, dollar values, personnel names, or financial metrics disclosed in the provided information. No positive or negative quantitative impacts, period-over-period comparisons, or guidance changes are mentioned.
- Β·Multi-item 8-K filing dated 2026-02-02 with AccNo: 0001213900-26-010533
- Β·Size: 1 MB (suggests exhibits present)
- Β·Sector: NOT_DISCLOSED
02-02-2026
Twist Bioscience Corp filed an 8-K on February 2, 2026 (AccNo: 0001581280-26-000016, Size: 293 KB), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period comparisons, guidance, or other quantitative financial metrics are disclosed in the provided filing description. This is an informational earnings-related disclosure with no directional performance indicators available.
- Β·AccNo: 0001581280-26-000016
- Β·File Size: 293 KB
- Β·Sector: not specified
02-02-2026
Anterix Inc. filed a Form 8-K on February 02, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the nature of the other events or the content of any exhibits provided in the summary. No quantitative metrics, financial impacts, or strategic details are disclosed.
02-02-2026
DOW INC. filed an 8-K on February 02, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing where specific details of the other events and any attached financial statements or exhibits are NOT_DISCLOSED in the provided information. No quantitative metrics, transactions, or directional impacts are mentioned.
- Β·AccNo: 0001751788-26-000015
- Β·File Size: 908 KB
02-02-2026
Stoneridge Inc. filed an 8-K on February 02, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.01 completion of an acquisition or disposition of assets. The filing also covers Item 5.02 changes in directors or certain officers, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. No quantitative metrics, deal values, parties involved, or financial terms are disclosed.
02-02-2026
Columbia Financial, Inc. filed a Form 8-K on February 2, 2026 (AccNo: 0001723596-26-000004), disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, guidance, or quantitative results such as revenue, earnings, or balance sheet changes are disclosed in the provided filing information. This is a standard earnings-related disclosure with attached exhibits.
02-02-2026
Harrow, Inc. filed an 8-K on 2026-02-02 disclosing results of operations and financial condition under Item 2.02, an officer change or departure under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), and financial statements and exhibits under Item 9.01. No specific details on the officer position, appointment/resignation status, reasons, financial metrics, or performance comparisons are disclosed in the provided filing information.
- Β·Filing Accession Number: 0001493152-26-004635
- Β·Filing Size: 317 KB
- Β·Sector: NOT_DISCLOSED
02-02-2026
Perspective Therapeutics, Inc. filed an 8-K on February 02, 2026, reporting under Item 2.02 Results of Operations and Financial Condition, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing related to financial results, but specific metrics, transaction details, and performance data are NOT_DISCLOSED. No quantitative financial impacts, period-over-period comparisons, or guidance revisions are provided in the available information.
02-02-2026
Clarivate PLC filed a Form 8-K on 2026-02-02 disclosing the termination of a material definitive agreement under Item 1.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No details on the agreement counterparty, termination reasons, financial impacts, or strategic effects were provided. No quantitative metrics, period-over-period comparisons, or performance data were mentioned.
02-02-2026
Wave Life Sciences Ltd. filed a Form 8-K on February 02, 2026 (AccNo: 0001193125-26-032698), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, exhibits, or any quantitative metrics are disclosed in the provided filing information. This is a multi-item informational filing with no evident positive or negative performance indicators.
02-02-2026
Columbia Financial, Inc. filed a Form 8-K on 2026-02-02 reporting entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific transaction details, dollar values, or financial metrics disclosed in the provided information. No positive or negative metrics are mentioned.
02-02-2026
Hain Celestial Group Inc filed a Form 8-K on February 2, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, disclosures, transaction size, financial impacts, or metrics provided in the available information. No positive, negative, or flat performance metrics are mentioned.
02-02-2026
Devon Energy Corp filed a multi-item 8-K on February 2, 2026, disclosing entry into a Material Definitive Agreement under Item 1.01, departure/election/appointment of directors/officers and compensatory arrangements under Item 5.02, Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No quantitative details, transaction values, personnel names, financial impacts, or performance metrics (positive, negative, or flat) are provided in the filing summary. This requires review of exhibits for full context.
02-02-2026
Textron Inc filed an 8-K on February 02, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.
02-02-2026
FIRST MERCHANTS CORP filed a Form 8-K on 2026-02-02 (AccNo: 0000712534-26-000013, Size: 206 KB) reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the nature of the other events or contents of the exhibits provided. No financial metrics, transactions, or directional impacts are disclosed.
02-02-2026
Quantum Corp /DE/ filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with additional Other Events under Item 8.01 and exhibits under Item 9.01. No specific details such as the key position affected, names of individuals, appointment or resignation status, reasons for the change, or any quantitative data are disclosed in the provided filing summary. No positive or negative metrics, financial impacts, or performance comparisons are mentioned.
02-02-2026
Yext, Inc. filed a Form 8-K on February 02, 2026, under Item 8.01 disclosing Other Events. No specific details on the nature of the event, financial metrics, transaction values, or impacts are provided in the filing metadata. This is a single-item voluntary disclosure with no quantitative data or period-over-period comparisons mentioned.
02-02-2026
VisionWave Holdings, Inc. filed an 8-K on February 02, 2026 (AccNo: 0001731122-26-000164, Size: 96 MB), reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing likely containing material disclosures and exhibits, but specific details of events, financials, or metrics are NOT_DISCLOSED in the provided information. No quantitative data, performance metrics, positive or negative changes, or directional implications extracted.
02-02-2026
Sierra Bancorp filed an 8-K on 2026-02-02 under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet metrics, period-over-period comparisons, or other quantitative financial details are provided in the filing summary. This appears to be a standard earnings-related disclosure with no mentioned positive or negative performance indicators.
02-02-2026
Alliance Resource Partners LP filed an 8-K on February 2, 2026 (AccNo: 0001104659-26-008972), reporting under Item 2.02 for results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, margins, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance data available.
02-02-2026
Braze, Inc. filed a Form 8-K on February 2, 2026, disclosing under Item 3.03 material modifications to rights of security holders, Item 5.03 amendments to articles of incorporation or bylaws (or change in fiscal year), Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details, numerical values, financial impacts, or directional metrics (positive, negative, or flat) are provided in the filing summary. This is a multi-item informational filing with no disclosed transaction values or performance comparisons.
- Β·AccNo: 0001676238-26-000006
- Β·Filing size: 180 KB
- Β·Event date: February 02, 2026
02-02-2026
Cloudastructure, Inc. filed a Form 8-K on 2026-02-02 reporting under Item 1.01 entry into a Material Definitive Agreement. Item 9.01 discloses Financial Statements and Exhibits. No specific details, transaction values, financial metrics, positive or negative impacts, or other quantitative data are provided.
- Β·Accession Number: 0001683168-26-000646
- Β·Filing size: 216 KB
02-02-2026
Digi Power X Inc. filed an 8-K on February 02, 2026 (AccNo: 0001213900-26-010550, Size: 255 KB) reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing includes voluntary disclosure of material information to comply with Regulation FD and attached exhibits, with no specific event details, financial metrics, or quantitative data provided in the filing metadata. No positive or negative metrics are disclosed.
02-02-2026
Hess Midstream LP filed an 8-K on 2026-02-02 disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. This appears to be a standard earnings-related disclosure. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are provided in the filing metadata.
02-02-2026
Strategy Inc filed a Form 8-K on February 02, 2026, reporting Item 7.01 Regulation FD Disclosure and Item 8.01 Other Events. No specific details, financial metrics, transactions, or scheduled events are disclosed in the filing summary. This appears to be a multi-item informational filing with no quantified impacts provided.
02-02-2026
PARK NATIONAL CORP /OH/ filed an 8-K on 2026-02-02 announcing the completion of an acquisition or disposition of assets under Item 2.01. The filing also covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements under Item 5.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific transaction details, financial metrics, parties involved, or impacts are disclosed.
- Β·Filing Accession Number: 0000805676-26-000010
- Β·File Size: 481 KB
02-02-2026
Gibraltar Industries, Inc. filed an 8-K on 2026-02-02 reporting entry into a new material definitive agreement (Item 1.01) and termination of a prior material definitive agreement (Item 1.02), alongside completion of an acquisition or disposition of assets (Item 2.01). The filing also discloses creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), potentially increasing leverage, with Regulation FD disclosure under Item 7.01. No quantitative deal terms, parties, or financial impacts are disclosed.
02-02-2026
Coterra Energy Inc. filed a Form 8-K on 2026-02-02 reporting multiple events: entry into a material definitive agreement (Item 1.01), departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements and exhibits (Item 9.01). No specific transaction details, financial metrics, personnel names, dollar values, or impacts are disclosed in the provided filing summary. This is a multi-item filing with no quantitative data available.
02-02-2026
Flowco Holdings Inc. filed a Form 8-K on February 02, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 3.02 unregistered sales of equity securities, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. No specific details, transaction values, financial impacts, or quantitative metrics are disclosed in the provided filing summary. This multi-item filing signals potentially significant corporate developments, but lacks substantive content for deeper assessment.
02-02-2026
VerifyMe, Inc. filed a Form 8-K on 2026-02-02 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the nature of the other events, financial impacts, transactions, or metrics are disclosed in the provided filing information. This appears to be a multi-item, primarily voluntary disclosure as Item 8.01 covers uncategorized material events.
02-02-2026
Claros Mortgage Trust, Inc. filed a multi-item Form 8-K on February 2, 2026, reporting entry into a material definitive agreement (Item 1.01) alongside termination of another material definitive agreement (Item 1.02). The filing also discloses creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), unregistered sales of equity securities (Item 3.02), amendments to articles of incorporation or bylaws or change in fiscal year (Item 5.03), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). No quantitative details, dollar values, or specific impacts were disclosed.
02-02-2026
Tharimmune, Inc. filed a Form 8-K on February 02, 2026, reporting under Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific vote outcomes, event details, or financial metrics disclosed in the provided information. No positive or negative metrics, changes, or comparisons are mentioned.
02-02-2026
02-02-2026
INNOVATE Corp. filed a Form 8-K on February 02, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of any financial statements or exhibits are disclosed in the provided filing information. This appears to be a multi-item filing with limited disclosure available.
02-02-2026
Cadre Holdings, Inc. filed a Form 8-K on 2026-02-02 disclosing under Item 1.01 the entry into a material definitive agreement. Item 9.01 indicates financial statements and exhibits are included. No specific details, transaction values, financial metrics, positive or negative impacts, or period-over-period comparisons are disclosed.
02-02-2026
TruGolf Holdings, Inc. filed a Form 8-K on February 02, 2026 (AccNo: 0001493152-26-004655, Size: 200 KB), reporting solely under Item 8.01 Other Events. No details on the core event, transaction, financial metrics, or impacts are disclosed in the provided information. This single-item filing represents a mandatory disclosure of material information not covered by other 8-K items.
02-02-2026
Agilysys Inc filed a Form 8-K on February 02, 2026, under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits), indicating a voluntary disclosure of material information likely via an attached exhibit such as a press release. This is a multi-item filing with no specific core event, transaction details, financial metrics, or performance comparisons disclosed. No positive or negative metrics are mentioned.
- Β·AccNo: 0001193125-26-032780
- Β·Event Type: General Filing
- Β·Source: us_sec
- Β·Sector: not specified
02-02-2026
Empery Digital Inc. filed a Form 8-K on February 02, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing information. This appears to be a multi-item informational filing with attached exhibits.
02-02-2026
NIQ Global Intelligence plc filed an 8-K on 2026-02-02 disclosing results of operations and financial condition under Item 2.02, departure or appointment of directors or certain officers including compensatory arrangements under Item 5.02, and financial statements and exhibits under Item 9.01. No specific details on officer positions, reasons for change, financial metrics, or performance comparisons are disclosed. No quantitative data or directional impacts are provided.
02-02-2026
02-02-2026
Northfield Bancorp, Inc. filed a Form 8-K on 2026-02-02 disclosing entry into a material definitive agreement under Item 1.01, departure/election/appointment of directors/officers and compensatory arrangements under Item 5.02, Regulation FD disclosure under Item 7.01, and financial statements/exhibits under Item 9.01. No specific details on the agreement, personnel changes, financial impacts, transaction values, or quantitative metrics are provided in the filing summary. This is a multi-item informational filing with no disclosed positive or negative financial metrics.
02-02-2026
Donaldson Co Inc filed an 8-K on 2026-02-02 reporting under Item 1.01 entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the agreement, transaction value, financial impacts, or quantitative metrics are disclosed in the provided filing information. This is a multi-item filing with no period-over-period comparisons, positive or negative metrics, or scheduled events mentioned.
02-02-2026
Inuvo, Inc. filed a Form 8-K on 2026-02-02 (AccNo: 0001654954-26-000799, Size: 146 KB) reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary disclosure as Item 8.01 covers company-deemed material events not specified elsewhere. No details on the specific events, transactions, financial statements, or exhibits are disclosed in the provided filing summary.
02-02-2026
BITMINE IMMERSION TECHNOLOGIES, INC. filed an 8-K on 2026-02-02 under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). No specific events, transactions, financial metrics, or other quantitative data are disclosed in the provided filing summary. The disclosure appears informational with attached exhibits.
02-02-2026
Open Text Corp filed an 8-K on 2026-02-02 under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other event, financial statements, exhibits, transactions, or metrics are disclosed in the provided filing summary. This appears to be an informational disclosure with no quantified positive or negative impacts mentioned.
02-02-2026
Hudson Technologies Inc. (/NY) filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on affected positions, individuals, reasons, timing, or impacts are disclosed.
02-02-2026
Avalon GloboCare Corp. filed a Form 8-K on February 2, 2026 (AccNo: 0001213900-26-010568, size 211 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific core events, transactions, financial metrics, positive or negative changes, or numerical data are disclosed in the provided filing information. This appears to be a multi-item, likely voluntary disclosure related to Regulation FD.
02-02-2026
Plumas Bancorp filed a Form 8-K on February 02, 2026 (AccNo: 0001437749-26-002609, Size: 182 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or contents of the exhibits are disclosed in the filing summary. This multi-item filing appears informational with no quantified positive or negative metrics provided.
02-02-2026
Sierra Bancorp filed an 8-K on February 2, 2026, reporting under Item 7.01 Regulation FD Disclosure. No specific financial metrics, transactions, events, positive or negative developments, or quantitative data are disclosed in the provided filing information. This appears to be a single-item voluntary disclosure.
02-02-2026
02-02-2026
iPower Inc. filed a Form 8-K on 2026-02-02 disclosing entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details provided on the agreement, events, transaction terms, or financial metrics.
02-02-2026
Barnwell Industries Inc filed a Form 8-K on 2026-02-02 reporting under Item 1.01 entry into a material definitive agreement, under Item 3.03 material modifications to rights of security holders, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details provided on the agreement, modifications, events, transaction values, financial impacts, or quantitative metrics. No positive or negative performance metrics are disclosed.
02-02-2026
Peakstone Realty Trust filed an 8-K on 2026-02-02 disclosing entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing reporting a material event, but specific details on the agreement, transaction terms, financial impacts, or quantitative metrics are NOT_DISCLOSED. No positive or negative metrics, period-over-period changes, or guidance revisions are mentioned.
02-02-2026
Pacific Biosciences of California, Inc. filed an 8-K on February 02, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.01 completion of an acquisition or disposition of assets. Item 7.01 provides Regulation FD disclosure, and Item 9.01 lists financial statements and exhibits. No specific deal structure, parties, valuation, financial metrics, or impacts are disclosed.
02-02-2026
COLUMBUS MCKINNON CORP filed an 8-K on February 02, 2026 (AccNo: 0001193125-26-032879, Size: 175 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing indicating voluntary public disclosure of material nonpublic information with attached exhibits. No quantitative financial metrics, transactions, positive or negative performance indicators, guidance, or other specific details are disclosed in the filing metadata.
02-02-2026
OFF THE HOOK YS INC. filed an 8-K on February 02, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No financial metrics, transactions, guidance, or specific events are detailed in the provided filing information. This is a multi-item filing likely involving voluntary disclosure of material information with attached exhibits.
02-02-2026
The company filed an 8-K on 2026-02-02 reporting under Item 7.01 (Regulation FD Disclosure) and Item 8.01 (Other Events), indicating disclosure of material nonpublic information and other material events. No specific details on events, transactions, financial metrics, positive or negative impacts, or quantitative data are provided in the filing summary. This is a multi-item filing with no mentioned period-over-period comparisons, guidance changes, or scheduled events.
02-02-2026
Ondas Holdings Inc. filed an 8-K on February 02, 2026, under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on events, transactions, financial metrics, or performance comparisons are disclosed in the provided filing summary. Critical content from the exhibits or disclosures is missing, limiting assessment of impact.
02-02-2026
Agape ATP Corp filed a Form 8-K on February 2, 2026, disclosing Item 5.07: Submission of Matters to a Vote of Security Holders. This reports the results of matters submitted to shareholders at a meeting, as required by SEC rules. No specific proposals, vote outcomes, numerical tallies, or other details are provided in the filing summary.
02-02-2026
Construction Partners, Inc. filed a Form 8-K on 2026-02-02 disclosing under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing likely providing voluntary information such as a press release or presentation as exhibits, with no specific core event, transaction, or financial metrics detailed in the provided filing summary. No positive or negative performance metrics reported.
02-02-2026
CME Group Inc. filed an 8-K on February 2, 2026 (AccNo: 0001156375-26-000002), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the disclosed information, financial metrics, transactions, or events provided in the filing metadata. No quantitative data, positive or negative metrics, or material impacts are mentioned.
02-02-2026
Oppenheimer Holdings Inc filed a Form 8-K on February 02, 2026 (AccNo: 0001628280-26-004480, Size: 2 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing indicates a voluntary disclosure of material information, likely accompanied by exhibits such as a press release or presentation. No quantitative financial metrics, transactions, period-over-period comparisons, or specific events are disclosed in the filing metadata.
02-02-2026
Advanced Drainage Systems, Inc. filed an 8-K on 2026-02-02 disclosing the completion of an acquisition or disposition of assets under Item 2.01. The filing includes Regulation FD disclosure under Item 7.01 and financial statements and exhibits under Item 9.01. No specific transaction details, parties, values, or financial metrics were disclosed in the provided filing summary.
02-02-2026
F&M BANK CORP filed an 8-K on February 2, 2026, under Item 2.02 reporting Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed performance data available.
02-02-2026
ENB Financial Corp filed an 8-K on 2026-02-02 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure of financial results. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics are disclosed.
02-02-2026
Flutter Entertainment plc filed a Form 8-K on 2026-02-02 under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits, with Accession Number 0001193125-26-033050 and file size 137 KB. No specific core event, transaction details, financial metrics, or quantitative data are disclosed in the filing summary. This is a voluntary informational disclosure without apparent positive or negative performance indicators.
02-02-2026
CAPITAL CITY BANK GROUP INC filed an 8-K on February 02, 2026, reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing involves a voluntary disclosure of material non-public information with attached exhibits, but specific details of the disclosure, financial metrics, transactions, or events are NOT_DISCLOSED. No quantitative data, period-over-period comparisons, or directional impacts are provided in the filing summary.
02-02-2026
02-02-2026
Auddia Inc. filed a Form 8-K on February 2, 2026, under Item 8.01 'Other Events'. No specific details regarding the nature of the event, financial impacts, transactions, or metrics are disclosed in the provided filing information. No positive or negative developments, scheduled events, or quantitative data are mentioned.
02-02-2026
HERITAGE FINANCIAL CORP /WA/ filed an 8-K on 2026-02-02 under Item 2.01 announcing the completion of an acquisition or disposition of assets. The filing also includes Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No quantitative deal terms, parties involved, strategic rationale, or financial metrics are disclosed.
02-02-2026
The company filed an 8-K on 2026-02-02 (AccNo: 0001140361-26-003134) disclosing a Credit Agreement under Item 8.01 Other Events, with the agreement provided as an exhibit under Item 9.01 Financial Statements and Exhibits. No specific financial terms, transaction values, or quantitative metrics are disclosed in the filing summary. This appears to be a material financing event, but lacks details on size, terms, or impact.
- Β·Event Type: Credit Agreement
- Β·Filing Size: 159 KB
- Β·Sector: NOT_DISCLOSED
02-02-2026
Inland Real Estate Income Trust, Inc. filed an 8-K on 2026-02-02 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative metrics are disclosed. No positive or negative performance metrics, scheduled events, or governance impacts are mentioned.
02-02-2026
OptimumBank Holdings, Inc. filed a Form 8-K on 2026-02-02 reporting results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or other quantitative financial metrics were disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with attached exhibits.
02-02-2026
E-Smart Corp. filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the key position affected, individuals involved, appointment or resignation status, reasons, timing, or compensation are disclosed. No quantitative financial metrics, performance comparisons, or other material data points are provided.
02-02-2026
The company filed an 8-K on February 02, 2026 (AccNo: 0001542447-26-000008, Size: 136 KB) under Item 8.01 Other Events, reporting a general event dated February 02, 2026. No specific details regarding the core event, financial metrics, transactions, or impacts are disclosed in the provided filing information. No quantitative data, named entities, or scheduled events are mentioned.
02-02-2026
T Stamp Inc filed a Form 8-K on February 02, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, financial statements, or exhibits are disclosed in the provided filing information. No quantitative metrics, transactions, or directional financial impacts are mentioned.
02-02-2026
SB Financial Group, Inc. filed a Form 8-K on 2026-02-02 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. This is a multi-item filing focused on financial results announcement. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided information.
02-02-2026
NAPCO Security Technologies, Inc. filed an 8-K on 2026-02-02 disclosing results of operations and financial condition under Item 2.02, departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific details on leadership changes, financial metrics, quantitative data, reasons for changes, or performance comparisons are explicitly stated in the provided filing information. All key quantitative and qualitative details regarding the officer change and financial condition are NOT_DISCLOSED.
02-02-2026
The company filed an 8-K on 2026-02-02 (AccNo: 0000081061-26-000031) under Item 1.01 announcing entry into a Material Definitive Agreement. No additional details on the agreement's nature, parties, financial terms, strategic importance, or impacts were explicitly stated in the provided filing information.
02-02-2026
The company filed an 8-K on February 02, 2026 (AccNo: 0001314152-26-000012) disclosing information under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the content of the Regulation FD disclosure, exhibits, financial metrics, transactions, or other quantitative data are provided in the filing summary. This appears to be a voluntary filing to comply with Regulation FD requirements.
02-02-2026
STANDARD MOTOR PRODUCTS, INC. filed a Form 8-K on 2026-02-02 under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits). No specific details regarding the other events or the nature of the attached financial statements and exhibits are disclosed in the provided filing information. This appears to be an informational disclosure without quantified metrics or directional impacts.
02-02-2026
KBS Real Estate Investment Trust III, Inc. filed a Form 8-K on 2026-02-02 disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. No specific details on the transaction, parties, dollar values, terms, or financial impacts were provided in the filing summary. This multi-item filing appears related to a financing event typical for REITs, with no positive or negative metrics disclosed.
02-02-2026
PROVECTUS BIOPHARMACEUTICALS, INC. filed a Form 8-K on 2026-02-02 disclosing under Item 5.03 amendments to its Articles of Incorporation or Bylaws or a change in fiscal year, accompanied by Item 9.01 Financial Statements and Exhibits. No specific details on the nature, effective date, or impact of the amendments or changes are provided. No quantitative financial metrics, positive or negative changes, or other performance data are mentioned.
02-02-2026
Regen BioPharma Inc filed an 8-K on February 2, 2026, specifically under Item 3.02 disclosing unregistered sales of equity securities. No quantitative details such as transaction value, share count, proceeds, or buyer information are disclosed. This is a single-item mandatory filing with no additional positive or negative metrics provided.
02-02-2026
Capitol Federal Financial, Inc. filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). No specific details on the key position affected, individual involved, nature of change (appointment or resignation), reasons, or timing are provided. No quantitative data, financial metrics, or further governance implications are mentioned.
02-02-2026
Palantir Technologies Inc. filed an 8-K on February 02, 2026, reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing likely pertains to financial results or material disclosures but contains no specific numerical data, metrics, or detailed outcomes in the provided summary. No positive, negative, or flat performance indicators are disclosed.
02-02-2026
Orion Energy Systems, Inc. filed an 8-K on February 2, 2026, reporting Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction terms, financial metrics, positive or negative impacts, or period-over-period comparisons are disclosed. This multi-item filing provides limited informational disclosure without quantified data.
02-02-2026
Capital One Financial Corp filed a Form 8-K on February 02, 2026 (AccNo: 0001193125-26-033632, Size: 613 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific other events, financial statements, or exhibits are disclosed. No quantitative metrics, comparisons, or directional impacts are provided.
02-02-2026
Axos Financial, Inc. filed an 8-K on February 02, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing involving voluntary disclosure of material information with attached exhibits. No specific financial metrics, transactions, or events are detailed in the provided filing summary.
02-02-2026
Snowflake Inc. filed an 8-K on 2026-02-02 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as affected positions (e.g., CEO, CFO), individuals involved, appointment or resignation status, reasons, or timing are provided in the available information. No quantitative metrics, financial impacts, or performance comparisons are mentioned.
02-02-2026
Capital Southwest Corp filed an 8-K on February 02, 2026 (AccNo: 0000017313-26-000010, Size: 5 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, guidance, or other quantitative metrics are mentioned in the provided information. No positive or negative performance indicators, period-over-period changes, or material financial impacts are detailed.
02-02-2026
Rambus Inc. filed a Form 8-K on 2026-02-02 (AccNo: 0001193125-26-033624) disclosing financial results under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing for earnings-related disclosures. No specific revenue, earnings, guidance, balance sheet effects, or other quantitative financial metrics are disclosed in the provided filing information.
02-02-2026
Scilex Holding Co filed an 8-K on February 2, 2026, disclosing entry into a material definitive agreement under Item 1.01. Item 9.01 includes financial statements and exhibits. No specific transaction details, financial metrics, or comparisons are disclosed.
02-02-2026
DaVita Inc. filed an 8-K on February 2, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition and under Item 9.01 providing Financial Statements and Exhibits. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics were mentioned in the filing summary provided. This appears to be a standard earnings-related disclosure without detailed performance data.
02-02-2026
Albertsons Companies, Inc. filed an 8-K on 2026-02-02 (AccNo: 0001646972-26-000019) reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, parties, financial metrics, positive or negative impacts, or period-over-period comparisons are disclosed. This is informational with no quantified data provided.
02-02-2026
Penguin Solutions, Inc. filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, and any names or effective dates are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.
02-02-2026
FRANKLIN FINANCIAL SERVICES CORP /PA/ filed an 8-K on February 02, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary filing with no specific core event, transaction details, financial metrics, or quantitative data disclosed in the provided filing information. Content of the disclosure and exhibits is NOT_DISCLOSED.
02-02-2026
Hormel Foods Corp /DE/ filed an 8-K on February 2, 2026, disclosing officer changes or appointments under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), submission of matters to a vote of security holders under Item 5.07, and financial statements and exhibits under Item 9.01. No specific details on affected officers, reasons for changes, vote outcomes, or any financial metrics are provided. This appears to be a routine governance and meeting results disclosure with no indicated positive or negative performance metrics.
02-02-2026
Beyond Air, Inc. filed a Form 8-K on February 2, 2026, reporting under Item 5.07 the submission of matters to a vote of security holders, likely results from a shareholder meeting. Item 9.01 discloses financial statements and exhibits. No specific vote outcomes, numerical metrics, positive or negative changes, or financial details are provided.
02-02-2026
Petco Health & Wellness Company, Inc. filed an 8-K on 2026-02-02 disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 references financial statements and exhibits. No specific transaction details, dollar values, strategic context, or financial impacts are disclosed.
02-02-2026
02-02-2026
FIRST BUSINESS FINANCIAL SERVICES, INC. filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative impacts are disclosed.
02-02-2026
ProKidney Corp. filed a Form 8-K on February 2, 2026, reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). Specific details of the Regulation FD disclosure, other events, financial statements, or exhibits are NOT_DISCLOSED. No quantitative metrics, period-over-period comparisons, positive or negative changes, or material events are provided in the filing summary.
02-02-2026
MGIC Investment Corp filed a Form 8-K on 2026-02-02 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. This is a standard voluntary disclosure for financial results with no specific revenue, earnings, or other metrics detailed in the provided filing information. No positive or negative performance indicators, comparisons, or guidance were mentioned.
- Β·Accession Number: 0000876437-26-000006
- Β·File Size: 911 KB
- Β·Sector: not specified
02-02-2026
Kforce Inc filed an 8-K on February 2, 2026 (AccNo: 0000930420-26-000003), reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits under Item 9.01. No specific financial metrics, revenue, earnings, guidance, period-over-period changes, or performance details (positive, negative, or flat) are disclosed in the provided filing information. This is an informational earnings-related disclosure without quantified data.
02-02-2026
Inspirato Inc filed an 8-K on February 2, 2026, reporting under Item 5.07 the submission of matters to a vote of security holders, likely results from a shareholder meeting. Item 9.01 discloses financial statements and exhibits were included. No specific vote outcomes, proposals, numerical results, or financial metrics are disclosed.
02-02-2026
Peoples Bancorp Inc filed an 8-K on 2026-02-02 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary filing to disclose material non-public information in compliance with Regulation FD and attach relevant exhibits. No financial metrics, transactions, or other quantitative details are explicitly stated in the filing summary provided.
02-02-2026
MIRA PHARMACEUTICALS, INC. filed a Form 8-K on February 02, 2026, under Item 8.01 Other Events. No specific details of the event, financial metrics, quantitative data, or period-over-period comparisons are disclosed in the provided filing information. This is a single-item voluntary disclosure with no mentioned positive or negative impacts.
02-02-2026
02-02-2026
Mitesco, Inc. filed an 8-K on February 2, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or contents of the exhibits are disclosed. This is a multi-item filing with limited information provided.
02-02-2026
Joby Aviation, Inc. filed a Form 8-K on 2026-02-02 reporting multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 2.02 (Results of Operations and Financial Condition), and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant), with Item 9.01 for Financial Statements and Exhibits. This is a multi-item mandatory filing, but specific details on the agreement, financial results, obligation terms, dollar values, or impacts are NOT_DISCLOSED.
02-02-2026
Vaxcyte, Inc. filed a Form 8-K on 2026-02-02 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits), indicating disclosure of a material event and related exhibits. Specific details of the other events, financial impacts, or metrics are NOT_DISCLOSED in the provided filing summary. No quantitative data, positive or negative metrics, or performance comparisons were mentioned.
02-02-2026
Jamf Holding Corp. disclosed in its 8-K filing on 2026-02-02 the entry into a new material definitive agreement (Item 1.01) and termination of a prior material definitive agreement (Item 1.02), alongside completion of an acquisition or disposition of assets (Item 2.01). However, the filing also reports creation of direct financial obligations (Item 2.03), triggering events accelerating those obligations (Item 2.04), notice of delisting or failure to satisfy listing standards (Item 3.01), material modifications to security holders' rights (Item 3.03), changes in control of the registrant (Item 5.01), and departures or elections of directors/officers (Item 5.02), indicating significant but unspecified corporate restructuring with both transactional completion and adverse listing/control changes.
02-02-2026
APPYEA, INC. filed a Form 8-K on February 02, 2026, disclosing unregistered sales of equity securities under Item 3.02 and attaching financial statements and exhibits under Item 9.01. No details on transaction size, share count, pricing, or parties involved were provided. This is a mandatory disclosure for certain unregistered equity issuances.
02-02-2026
Woodward, Inc. filed a Form 8-K on February 2, 2026 (AccNo: 0001171843-26-000562), disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. This is a multi-item voluntary filing typical for earnings releases, but no specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are detailed in the provided information.
02-02-2026
LCNB Corp filed an 8-K on 2026-02-02 under Item 7.01 Regulation FD Disclosure, indicating a voluntary release of material non-public information to ensure fair disclosure, with exhibits attached under Item 9.01 Financial Statements and Exhibits. No specific transaction details, financial metrics, positive or negative changes, or quantitative data are disclosed in the filing metadata. This is purely informational with no directional financial implications evident.
02-02-2026
Strategy Inc filed a Form 8-K on February 02, 2026 (AccNo: 0001193125-26-033573, Size: 287 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or contents of the exhibits are disclosed in the provided filing summary. This is a multi-item filing with no quantitative financial metrics, transaction details, or directional performance indicators mentioned.
02-02-2026
The company filed a Form 8-K on 2026-02-02 (AccNo: 0001193125-26-033572) under Item 5.02 disclosing an officer change involving Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; or Compensatory Arrangements of Certain Officers. No specific details such as officer name, title (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, or effective date beyond the filing date are explicitly stated. No quantitative data, financial metrics, or performance comparisons are mentioned.
02-02-2026
Palomar Holdings, Inc. filed an 8-K on February 02, 2026, disclosing entry into a material definitive agreement (Item 1.01), completion of an acquisition or disposition of assets (Item 2.01), creation of a direct financial obligation (Item 2.03), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific deal structure, parties, valuation, synergies, or financial impacts are disclosed in the provided filing summary. Critical transaction details remain NOT_DISCLOSED, limiting assessment of shareholder or market implications.
02-02-2026
vTv Therapeutics Inc. filed an 8-K on 2026-02-02 disclosing under Item 1.01 its entry into a Material Definitive Agreement. No details on the core event, transaction parties, dollar value, financial impacts, or strategic importance are provided in the available information. No quantitative metrics, guidance changes, or scheduled events are mentioned.
02-02-2026
Healthpeak Properties, Inc. filed an 8-K on February 2, 2026 (AccNo: 0001628280-26-004623), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results with attached statements and exhibits, but no specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the available information. No positive or negative performance indicators, period-over-period changes, or scheduled events are mentioned.
02-02-2026
Century Aluminum Co filed an 8-K on 2026-02-02 disclosing entry into a material definitive agreement under Item 1.01 and completion of an acquisition or disposition of assets under Item 2.01. The filing also includes Regulation FD disclosure under Item 7.01 and financial statements/exhibits under Item 9.01. No specific transaction details, parties, values, or financial metrics are disclosed.
02-02-2026
GENELUX Corp filed an 8-K on February 02, 2026 (AccNo: 0001493152-26-004755, size: 40 MB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses material nonpublic information pursuant to Regulation FD with attached exhibits, but no specific transaction details, financial metrics, or events are stated in the provided summary. No quantitative data, period-over-period comparisons, or directional metrics (positive, negative, or flat) are mentioned.
02-02-2026
FEDERAL AGRICULTURAL MORTGAGE CORP filed an 8-K on February 02, 2026, reporting amendments to its Articles of Incorporation or Bylaws or a change in fiscal year under Item 5.03, with financial statements and exhibits provided under Item 9.01. No specific details on the nature or impact of the amendments, quantitative metrics, transaction values, or financial implications are disclosed in the filing summary. This appears to be an informational governance update with no directional financial data provided.
02-02-2026
XCEL ENERGY INC filed an 8-K on 2026-02-02 reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant), indicating a new financing-related agreement. Item 9.01 includes Financial Statements and Exhibits. No specific transaction details, dollar values, terms, or financial impacts are disclosed.
02-02-2026
Simply Good Foods Co filed an 8-K on 2026-02-02 disclosing an officer change or director departure/election under Item 5.02, including compensatory arrangements. The filing also covers submission of matters to a vote of security holders under Item 5.07 and financial statements/exhibits under Item 9.01. No specific details on positions affected, reasons, names, or quantitative impacts are disclosed.
02-02-2026
FIRST FINANCIAL BANCORP /OH/ filed an 8-K on 2026-02-02 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits), with a filing size of 9 MB. No specific financial metrics, transactions, positive or negative changes, or operational details are disclosed in the provided filing summary. This appears to be a voluntary disclosure to comply with Regulation FD, potentially including attached exhibits such as presentations.
- Β·AccNo: 0000708955-26-000011
- Β·Filing size: 9 MB
- Β·Event Type: General Filing
- Β·Multi-item 8-K: Items 7.01 and 9.01
02-02-2026
Onity Group Inc. filed an 8-K on 2026-02-02 disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides for financial statements and exhibits. No specific transaction details, dollar values, strategic impacts, or financial metrics are disclosed.
02-02-2026
Two Harbors Investment Corp. filed an 8-K on February 2, 2026 (AccNo: 0001465740-26-000003), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This constitutes a multi-item filing announcing financial results with attached exhibits. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information.
02-02-2026
Braemar Hotels & Resorts Inc. filed an 8-K on February 2, 2026 (AccNo: 0001574085-26-000013, Size: 367 KB) reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the content of the Regulation FD disclosure, financial statements, exhibits, transactions, metrics, or events are explicitly stated in the filing summary provided. This appears to be a voluntary disclosure with attached materials, but core event details are NOT_DISCLOSED.
02-02-2026
Nelnet Inc filed an 8-K on February 2, 2026, under Item 8.01 disclosing Other Events. No specific details regarding the nature of the events, financial impacts, quantitative metrics, or strategic implications are provided in the filing summary. No positive or negative metrics are mentioned.
02-02-2026
Simon Property Group Inc. filed an 8-K on February 02, 2026 (AccNo: 0001104659-26-009209), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results, but specific revenue, earnings, guidance, or period-over-period metrics are NOT_DISCLOSED. No positive, negative, or flat performance indicators are provided in the filing details.
02-02-2026
AMKOR TECHNOLOGY, INC. filed an 8-K on 2026-02-02 (AccNo: 0001047127-26-000003, Size: 138 KB) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions (e.g., CEO, CFO), individuals involved, reasons for change, effective dates, or internal/external nature are provided. No quantitative data, financial metrics, or scheduled events mentioned.
02-02-2026
TERAWULF INC. filed an 8-K on February 02, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the financial statements and exhibits are disclosed. This is a multi-item filing with no quantitative metrics, positive or negative developments, or directional implications provided.
02-02-2026
Greenland Technologies Holding Corp. filed a Form 8-K on February 2, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 5.07 submission of matters to a vote of security holders, with Item 9.01 providing financial statements and exhibits. No specific details, dollar values, vote outcomes, or quantitative financial impacts are disclosed in the provided filing summary. No positive or negative metrics are mentioned.
02-02-2026
Sky Quarry Inc. filed an 8-K on 2026-02-02 disclosing an officer or director change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits were included. Specific details such as the key position affected, individual names, appointment or resignation status, reasons, or timing are NOT_DISCLOSED.
02-02-2026
FIRST UNITED CORP/MD/ filed an 8-K on 2026-02-02 under Item 5.02 disclosing matters related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on key positions affected, individuals involved, reasons for changes, timing, or any quantitative financial impacts are disclosed. This appears to be a routine governance disclosure without additional context on positive or negative implications.
02-02-2026
ZYNEX INC filed a Form 8-K on 2026-02-02 under Item 1.03 disclosing Bankruptcy or Receivership. No financial metrics, transaction values, dollar amounts, or other quantitative details are provided in the filing summary. This represents a material negative event with no offsetting positive disclosures.
02-02-2026
Bally's Corp filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, timing, or any named executives are NOT_DISCLOSED. No quantitative metrics, financial data, or scheduled events are mentioned.
02-02-2026
Nordson Corp filed an 8-K on 2026-02-02 disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 lists financial statements and exhibits. No specific details, dollar values, terms, or impacts are disclosed in the provided filing summary.
02-02-2026
The company filed an 8-K on February 2, 2026 (AccNo: 0001104659-26-009237), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the nature of the agreement, size of the financial obligation, transaction value, parties involved, or financial impacts are disclosed in the provided filing summary. Quantitative metrics, period-over-period comparisons, and strategic context are NOT_DISCLOSED.
02-02-2026
EVERTEC, Inc. filed a Form 8-K on 2026-02-02 disclosing Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing covering a core material event with attached exhibits. No specific details on the agreement terms, financial impacts, or quantitative metrics are disclosed in the provided information.
02-02-2026
S&T Bancorp Inc filed an 8-K on February 2, 2026, reporting under Item 5.03 amendments to Articles of Incorporation or Bylaws or change in fiscal year, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details, transaction values, financial metrics, or period-over-period comparisons are disclosed in the provided filing information.
02-02-2026
NightFood Holdings, Inc. filed an 8-K on February 02, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the disclosure content, financial metrics, transactions, or events are explicitly stated in the filing summary. No quantitative data, period-over-period comparisons, or material events are disclosed.
02-02-2026
Kadant Inc. filed an 8-K on February 2, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing information. The nature of the Regulation FD disclosure and contents of exhibits are NOT_DISCLOSED.
02-02-2026
Empire Petroleum Corp filed a Form 8-K on February 02, 2026, disclosing Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No specific details regarding the nature of the other events, transaction values, financial metrics, or exhibits are explicitly stated in the filing summary. This appears to be a multi-item filing focused on voluntary disclosure of potentially material information.
02-02-2026
FiEE, Inc. filed a multi-item Form 8-K on February 2, 2026, reporting entry into a material definitive agreement under Item 1.01, results of operations and financial condition under Item 2.02, and unregistered sales of equity securities under Item 3.02, accompanied by financial statements and exhibits under Item 9.01. No specific transaction details, financial metrics, dollar values, share counts, or performance comparisons (positive, negative, or flat) were disclosed in the provided filing summary. This disclosure signals potentially significant developments but lacks quantification for impact assessment.
02-02-2026
Janus International Group, Inc. filed a Form 8-K on 2026-02-02 disclosing under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item filing indicating significant corporate developments involving a new agreement and financial commitment. No specific transaction details, dollar values, or financial impacts are disclosed.
02-02-2026
Sezzle Inc. filed an 8-K on February 02, 2026, reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific financial metrics, quantitative data, period-over-period comparisons, or guidance were disclosed in the provided filing details. This appears to be a standard earnings-related disclosure.
02-02-2026
Goldman Sachs Group Inc filed an 8-K on February 2, 2026, solely under Item 9.01 Financial Statements and Exhibits, indicating attachment of unspecified financial statements or exhibits (file size 344 KB). No specific events, transactions, metrics, or details are disclosed in the filing summary. This appears to be an informational exhibit filing with no directional financial impact evident.
02-02-2026
Veradigm Inc. filed an 8-K on February 2, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 3.03 material modifications to rights of security holders, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. No specific details on the agreement, modifications, or disclosures are provided in the filing summary. No quantitative financial impacts, positive or negative metrics, or period-over-period comparisons are disclosed.
02-02-2026
UNITED STATES LIME & MINERALS INC filed an 8-K on 2026-02-02 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are mentioned in the filing summary. Sector information is not specified.
02-02-2026
Fabrinet filed an 8-K on February 02, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative metrics are disclosed in the provided filing details. This appears to be a standard earnings-related disclosure without detailed financial data available.
02-02-2026
The company filed an 8-K on February 02, 2026, disclosing entry into a Material Definitive Agreement under Item 1.01 and creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement under Item 2.03, accompanied by Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the agreement, transaction value, financial terms, or impacts are disclosed in the provided filing summary. No quantitative metrics, guidance changes, or performance comparisons are mentioned.
02-02-2026
Atlas Energy Solutions Inc. filed an 8-K on 2026-02-02 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, titles, reasons for change, timing, or any quantitative impacts were mentioned. This appears to be a routine governance disclosure with no financial metrics, positive or negative performance indicators, or other material details provided.
02-02-2026
Bark, Inc. filed a Form 8-K on February 2, 2026 (AccNo: 0001628280-26-004626), disclosing an unspecified event under Item 8.01 (Other Events). No financial metrics, transaction details, quantitative data, positive or negative changes, or operational impacts were mentioned. Sector information was not specified.
02-02-2026
BellRing Brands, Inc. filed an 8-K on February 2, 2026 (AccNo: 0001628280-26-004642), reporting under Item 5.07 the submission of matters to a vote of security holders. No specific proposals, vote results, numerical outcomes, or other details are disclosed in the provided filing information. This is a standard informational disclosure on shareholder meeting votes with no financial metrics or directional implications mentioned.
02-02-2026
Encompass Health Corp filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02, covering potential departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or quantitative impacts are disclosed.
02-02-2026
Quaint Oak Bancorp, Inc. filed a Form 8-K on February 2, 2026 (AccNo: 0000927089-26-000017), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a multi-item filing for financial results announcement. No specific revenue, earnings, balance sheet changes, guidance, or quantitative metrics are detailed in the provided filing information.
02-02-2026
MIDDLEBY Corp filed an 8-K on 2026-02-02 (AccNo: 0001193125-26-033775, Size: 165 KB) under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, financial statements, exhibits, or any quantitative metrics are disclosed in the provided filing information. No positive or negative performance indicators are mentioned.
02-02-2026
Goldman Sachs BDC, Inc. filed an 8-K on February 2, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, or financial impacts are disclosed.
02-02-2026
DAKTRONICS INC /SD/ filed an 8-K on 2026-02-02 disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits accompany the filing. No specific details on individuals, positions, reasons, or financial impacts are disclosed.
02-02-2026
XOMA Royalty Corp filed an 8-K on 2026-02-02 disclosing the completion of an acquisition or disposition of assets under Item 2.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on transaction parties, structure, value, or financial impacts are disclosed. No quantitative metrics, positive or negative changes, or period-over-period comparisons are provided.
02-02-2026
Flexsteel Industries Inc filed a Form 8-K on 2026-02-02 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results, but no specific revenue, earnings, balance sheet details, guidance, or quantitative metrics are provided in the filing information. No positive or negative performance indicators, period-over-period changes, or transaction values are mentioned.
02-02-2026
DarioHealth Corp. filed a Form 8-K on February 2, 2026, under Item 5.03 disclosing amendments to its Articles of Incorporation or Bylaws or a change in fiscal year, accompanied by Item 9.01 for financial statements and exhibits. No quantitative financial metrics, transaction values, or specific details on the amendments' nature, impacts, or strategic implications were provided.
02-02-2026
Installed Building Products, Inc. filed a Form 8-K on February 02, 2026 (AccNo: 0001628280-26-004634), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific quantitative metrics, transactions, or operational details disclosed in the provided summary. No positive or negative financial changes, guidance, or events are mentioned.
02-02-2026
NEW JERSEY RESOURCES CORP filed an 8-K on February 02, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific revenue, earnings, guidance, or period-over-period metrics in the available information. No positive or negative financial changes are detailed, resulting in purely informational disclosure.
02-02-2026
APARTMENT INVESTMENT & MANAGEMENT CO filed a Form 8-K on February 02, 2026, disclosing an unspecified Other Event under Item 8.01. No quantitative data, financial impacts, transaction details, or other metrics are mentioned in the filing information provided. This is a voluntary single-item disclosure with no further specifics on the event.
02-02-2026
Avidia Bancorp, Inc. filed an 8-K on February 2, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance data available.
02-02-2026
Advanced Biomed Inc. filed a Form 8-K on February 2, 2026, reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, accompanied by financial statements and exhibits under Item 9.01. This multi-item filing signals a potentially strategic transaction alongside possible dilutive equity issuance, but specific terms, values, or impacts remain undisclosed. No quantitative financial metrics, guidance changes, or performance comparisons are provided.
02-02-2026
Profusa, Inc. filed an 8-K on February 2, 2026, under Item 5.07 reporting the submission of matters to a vote of security holders following a shareholder meeting. No specific proposals, vote results, or numerical outcomes are disclosed in the provided filing summary. This is a standard post-meeting informational disclosure with no financial or operational metrics reported.
02-02-2026
Vicarious Surgical Inc. filed an 8-K on 2026-02-02 disclosing an unspecified officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included, but specific details are NOT_DISCLOSED. No quantitative metrics, performance comparisons, or directional impacts are provided in the filing summary.
02-02-2026
Newbridge Acquisition Ltd filed an 8-K on 2026-02-02 disclosing entry into a Material Definitive Agreement under Item 1.01, likely related to a merger or acquisition, along with unregistered sales of equity securities (Item 3.02), amendments to articles of incorporation or bylaws and/or change in fiscal year (Item 5.03), other events (Item 8.01), and financial statements and exhibits (Item 9.01). No quantitative metrics, deal terms, parties beyond the filer, valuations, synergies, or performance comparisons (positive, negative, or flat) are disclosed. Critical details such as target company, deal structure, consideration, and timeline remain NOT_DISCLOSED.
02-02-2026
Quince Therapeutics, Inc. filed an 8-K on 2026-02-02 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative impacts are provided. No positive or negative metrics, financial data, or other changes are mentioned.
02-02-2026
Petco Health & Wellness Company, Inc. filed an 8-K on 2026-02-02 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 7.01 covers Regulation FD Disclosure. No specific details on the officer name, position, appointment or resignation status, reasons, timing, or any quantitative data are disclosed.
02-02-2026
Community Health Systems Inc filed an 8-K on 2026-02-02 announcing the completion of an acquisition or disposition of assets under Item 2.01. Item 8.01 discloses other events, and Item 9.01 provides financial statements and exhibits. No specific details on transaction parties, value, structure, or financial impacts are disclosed.
02-02-2026
The company filed a Form 8-K on February 2, 2026, disclosing an unregistered sale of equity securities under Item 3.02. No quantitative details such as transaction value, share count, price, purchasers, or purpose were provided in the filing information available. This is a single-item filing with no additional financial metrics, guidance, or comparisons disclosed.
02-02-2026
Element Solutions Inc filed an 8-K on 2026-02-02 disclosing Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, financial obligation, dollar values, strategic impacts, or metrics are disclosed in the provided information. This is a multi-item mandatory filing with no quantitative data available.
02-02-2026
Walker & Dunlop, Inc. filed an 8-K on February 02, 2026 (AccNo: 0001104659-26-009264), reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement). Item 9.01 discloses Financial Statements and Exhibits. No transaction details, dollar values, financial impacts, or other metrics are provided.
02-02-2026
BrooQLy Inc. filed a Form 8-K on February 02, 2026, under Item 5.03 disclosing amendments to Articles of Incorporation or Bylaws or a change in fiscal year, Item 8.01 for other events, and Item 9.01 for financial statements and exhibits. No specific details, numerical values, transaction sizes, or financial impacts are disclosed in the filing summary. This is a multi-item informational filing with no directional metrics provided.
02-02-2026
Farmers & Merchants Bancorp filed a Form 8-K on February 2, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing likely providing material non-public information previously disclosed selectively, with supporting exhibits attached. No specific financial metrics, transactions, or performance details are disclosed in the filing summary.
02-02-2026
Farmers & Merchants Bancorp filed an 8-K on February 2, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons were disclosed in the filing details. This appears to be a standard earnings-related disclosure without quantified metrics.
02-02-2026
Lexicon Pharmaceuticals, Inc. filed a Form 8-K on February 2, 2026, reporting multiple events under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific transaction values, financial metrics, share counts, or directional impacts were disclosed. The filing appears informational without quantified positive or negative metrics.
02-02-2026
RCI Hospitality Holdings, Inc. filed Form 8-K on 2026-02-02 under Item 3.01 announcing a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. Item 9.01 discloses Financial Statements and Exhibits. No specific reasons, timelines, financial impacts, or quantitative details are provided.
02-02-2026
Unitil Corp filed an 8-K on February 2, 2026, reporting entry into a material definitive agreement under Item 1.01, departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements under Item 5.02, with financial statements and exhibits under Item 9.01. No specific details, dollar values, personnel names, transaction sizes, or financial impacts are disclosed in the provided filing summary. This is a multi-item informational filing with no quantified positive or negative metrics available.
02-02-2026
AIxCrypto Holdings, Inc. filed an 8-K on 2026-02-02 reporting under Item 1.01 entry into a material definitive agreement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details, transaction values, financial metrics, or directional impacts are disclosed in the provided filing summary. This is a multi-item filing with no quantified positive or negative metrics available.
02-02-2026
EverSpin Technologies Inc. filed a Form 8-K on February 2, 2026 (AccNo: 0001628280-26-004681, Size: 142 KB), reporting under Item 8.01 Other Events. No specific details on the nature of the event, financial metrics, transactions, or impacts are disclosed. No positive, negative, or flat performance metrics are mentioned.
02-02-2026
The company filed a Form 8-K on February 02, 2026 (AccNo: 0001539497-26-000247, Size: 29 MB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, financial statements, exhibits, transaction values, metrics, or impacts are disclosed in the provided filing information. This appears to be a multi-item voluntary disclosure with no quantitative data or directional implications provided.
02-02-2026
SIMMONS FIRST NATIONAL CORP filed an 8-K on 2026-02-02 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the individuals involved, positions affected, reasons for the change, or any financial metrics are disclosed in the provided filing information. No positive or negative metrics are mentioned.
02-02-2026
Triller Group Inc. filed a Form 8-K on February 02, 2026, reporting changes in its certifying accountant under Item 4.01. Item 9.01 discloses financial statements and exhibits. No specific details, quantitative impacts, reasons for the change, or financial metrics are provided.
02-02-2026
Armstrong World Industries Inc. filed a Form 8-K on 2026-02-02 (AccNo: 0001193125-26-033816, Size: 154 KB) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or any quantitative metrics are disclosed. Sector is not specified.
- Β·Filing Accession Number: 0001193125-26-033816
- Β·Filing Size: 154 KB
02-02-2026
Lazard, Inc. filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure (Item 7.01), Other Events (Item 8.01), and Financial Statements and Exhibits (Item 9.01). Specific details including the key position affected, appointment or resignation status, reasons, and timing are NOT_DISCLOSED. No quantitative financial metrics, named executives, or scheduled events are mentioned.
02-02-2026
Esquire Financial Holdings, Inc. filed an 8-K on February 2, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or the content of the exhibits are provided. This appears to be a voluntary informational filing with no quantified financial metrics or directional impacts disclosed.
02-02-2026
BlackLine, Inc. filed a Form 8-K on February 2, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the financial statements and exhibits are disclosed in the filing summary.
02-02-2026
Terex Corp filed an 8-K on 2026-02-02 announcing the completion of an acquisition or disposition of assets under Item 2.01. The filing also reports departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements under Item 5.02, along with other events under Item 8.01. Financial statements and exhibits are included under Item 9.01; no specific transaction details, financial metrics, or performance changes are disclosed.
02-02-2026
MDB Capital Holdings, LLC filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative impacts are disclosed.
02-02-2026
HF Foods Group Inc. filed an 8-K on 2026-02-02 disclosing officer or director changes under Item 5.02, which includes departures, elections, appointments, or compensatory arrangements of certain officers. Item 9.01 references attached financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for changes, or any quantitative metrics were provided.
02-02-2026
NRX Pharmaceuticals, Inc. filed an 8-K on 2026-02-02 under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including key positions affected, names of individuals, reasons for changes, timing, or any quantitative metrics are provided. No positive or negative performance metrics are mentioned.
02-02-2026
Chemung Financial Corp filed an 8-K on 2026-02-02 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits), indicating a voluntary release of material information with attached documents. The filing size is 8 MB, suggesting possible press releases, presentations, or financial exhibits. No specific transaction details, financial metrics, positive or negative changes, or events are disclosed in the provided information.
02-02-2026
SunPower Inc. filed an 8-K on 2026-02-02 disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). The filing also reports unregistered sales of equity securities (Item 3.02) and attaches financial statements and exhibits (Item 9.01). No specific transaction details, parties, values, or metrics are disclosed.
02-02-2026
Olympic Steel Inc filed an 8-K on February 2, 2026, reporting solely under Item 8.01 Other Events. No specific details regarding the core event, financial impacts, transactions, metrics, or scheduled events are disclosed. This is a voluntary, single-item informational filing with no quantitative data provided.
02-02-2026
Dayforce, Inc. filed an 8-K on February 02, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of any exhibits are disclosed in the filing metadata. This appears to be a multi-item informational filing with no quantified financial metrics or directional indicators provided.
02-02-2026
Mawson Infrastructure Group Inc. filed an 8-K on 2026-02-02 reporting multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details, transaction values, financial impacts, or quantitative metrics are disclosed in the provided filing summary. This multi-item filing indicates significant corporate governance and agreement changes, but lacks context to assess positive or negative implications.
02-02-2026
Ashland Inc. filed an 8-K on February 2, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or quantitative data were disclosed in the provided filing information. This is a multi-item filing typical for earnings releases, but lacks detailed performance data for analysis.
02-02-2026
Atkore Inc. filed an 8-K on February 2, 2026, under Item 5.07 reporting the submission of matters to a vote of security holders, typically indicating results from a shareholder meeting such as director elections or compensation approvals. Item 9.01 discloses financial statements and exhibits were attached. No vote outcomes, numerical results, financial metrics, or directional impacts provided in the filing details.
02-02-2026
KRAKacquisition Corp filed an 8-K on 2026-02-02 disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), departures/elections/appointments of directors/officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws or change in fiscal year (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). This filing structure is consistent with a SPAC de-SPAC merger process. No specific transaction parties, values, financial metrics, synergies, or other quantitative details are disclosed.
02-02-2026
SPX Technologies, Inc. filed an 8-K on 2026-02-02 under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, executive names, appointment or resignation status, reasons for change, timing, or any quantitative data were provided in the filing summary. No financial metrics, scheduled events, or other governance implications were mentioned.
02-02-2026
International Business Machines Corp (IBM) filed an 8-K on February 2, 2026, solely under Item 9.01: Financial Statements and Exhibits. No specific financial metrics, transactions, period-over-period comparisons, or material events are disclosed in the filing details provided. This is an informational filing with attached exhibits but lacks quantitative data or directional impacts.
02-02-2026
Greif, Inc. filed a Form 8-K on February 02, 2026 (AccNo: 0001628280-26-004695), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific revenue, earnings, guidance, or other quantitative metrics. No positive or negative performance indicators, scheduled events, or transaction details are mentioned.
02-02-2026
STONERIDGE INC filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, and any quantitative data are NOT_DISCLOSED. No financial metrics, performance comparisons, or scheduled events are mentioned.
02-02-2026
ImmuCell Corp filed an 8-K on February 2, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 discloses financial statements and exhibits. No specific transaction details, personnel names, financial impacts, dollar values, or quantitative metrics are disclosed.
02-02-2026
DALRADA FINANCIAL CORP filed an 8-K on February 2, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, parties, terms, financial impacts, or quantitative metrics are disclosed in the provided filing summary.
02-02-2026
Blackwell 3D Construction Corp. filed a Form 8-K on 2026-02-02 reporting Item 5.06, announcing a change in shell company status. This indicates the company is no longer classified as a shell company. No financial metrics, transaction details, or other quantitative data were disclosed.
02-02-2026
Shuttle Pharmaceuticals Holdings, Inc. filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons for change, or financial metrics are disclosed.
Get daily alerts with 11 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 274 filings
πΊπΈ More from United States
View all βMarch 25, 2026
US Pre-Market SEC Filings Roundup β March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings β March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings β March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC β March 24, 2026
US Executive Officer Management Changes SEC